Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Debt Growth Recovery in ProgressRecovering
Percentile Rank83
3Y CAGR-90.9%
Studio
Year-over-Year Change

Year-over-year debt growth rate

3Y CAGR
-90.9%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
20245.77%
2023-97.31%
2022-40.13%
20217721.13%
2020173.40%
2019-98.99%
20180.00%
2017-100.00%
2016-57.68%
2015-22.91%